⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VNRX News
VolitionRX Limited Common Stock
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Form 8-K
sec.gov
VNRX
VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
prnewswire.com
VNRX
Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
prnewswire.com
VNRX
VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
prnewswire.com
VNRX
Volition Advances Nu.Q® NETs Platform Towards Commercialization
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX